PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la découverte et au développement de thérapies géniques innovantes pour le traitemen…
Author: Business Wire
GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative disease…
More than meets the eye: Bosch enables the next generation of smartglasses
FARMINGTON HILLS, Mich.–(BUSINESS WIRE)–At CES® in Las Vegas, Nevada, Bosch Sensortec will launch an innovative optical Light Drive system for smartglasses. The Bosch Smartglasses Light Drive module is a sole source, all-in-one technology stack consi…
FocalPoint Holdings Partners with GreenSky Patient Solutions® to Enable 8,000 Ophthalmology Providers to Provide Patient Financing
ATLANTA–(BUSINESS WIRE)—- $GSKY #eyedoctor–FocalPoint Holdings Partners with GreenSky Patient Solutions® to Enable 8,000 Ophthalmology Providers to provide Patient Financing
Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX) and AgeX Therapeutics, Inc. (NYSE American: AGE), announced today that the United States Patent and Trademark Office (USPTO) has issued U.S…
EnChroma Launches Scenic Viewers for Color Blindness in Partnership with SeeCoast
BERKELEY, Calif. & FAIRHOPE, Ala.–(BUSINESS WIRE)– #colorishere–EnChroma lens technology for color blindness is available in scenic viewers made by SeeCoast, enabling the color blind to enjoy the colors of nature.
Global Glaucoma Surgery Devices Market 2019-2023| Evolving Opportunities with ALLERGAN and Carl Zeiss Meditec | Technavio
LONDON–(BUSINESS WIRE)– #glaucomasurgerydevices–Technavio has been monitoring the global glaucoma surgery devices market since 2016 and the market is poised to grow by USD 1 billion during 2019-2023
Aurinia Prices US$166.7 Million Public Offering of Common Shares
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced th…
Global Optic Neuropathy Pipeline Review, H2 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuropathy – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. The review provi…
Canon Inc. Realigns Strategy to Prepare for Eye Care Systems Business Growth
TUSTIN, Calif.–(BUSINESS WIRE)–As part of Canon Inc.’s global medical business strategic realignment, the eye care business operations within Canon U.S.A. Inc. will transfer to Canon Medical Systems USA, Inc. effective January 1, 2020. Canon’s shift …
Aerie Pharmaceuticals Announces Appointment of Amine Sinmazisik as Director, Finance
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
L’hôpital des Quinze-Vingts et GenSight Biologics annoncent une 1ère Autorisation Temporaire d’Utilisation (ATU) de LUMEVOQ™ (GS010) en France
PARIS–(BUSINESS WIRE)–Regulatory News: Le Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts à Paris et GenSight Biologics (Paris:SIGHT) (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la décou…
The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France
PARIS–(BUSINESS WIRE)–Regulatory News: The National Eye Hospital (CHNO) of the Quinze-Vingts in Paris and GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and develop…
Global Cataract Surgery Devices and Equipment Market Report 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices And Equipment Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global cataract surgery devices and equipment market was valued at about $3.4 billion in 201…
IVERIC bio, Inc. Announces Proposed Offering of Common Stock
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that it is commencing an underwritten public offering of shares of its common stock.
Opportunities in Global Ophthalmic Surgery Markets, 2019 & Beyond – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Opportunities in Global Ophthalmic Surgery Markets” report has been added to ResearchAndMarkets.com’s offering. Coverage in this report includes a detailed analysis of the current and forecast markets for ophthalmic surger…
Limelight Bio Emerges with $75 Million to Develop Next Generation Gene Therapies to Overcome Limitations of Current Treatments
PHILADELPHIA & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Limelight Bio, a privately held, multi-platform, multi-disease biopharmaceutical company developing novel gene therapies, raised $75 million in new financing funded by Apple Tree Partners (ATP), a leadi…
Vivior e SwissLens danno vita a un partenariato per lo sviluppo di lenti a contatto personalizzate
ZURIGO–(BUSINESS WIRE)–Le due società elvetiche accettano di collaborare nel campo della correzione della presbiopia tramite lenti a contatto morbide multifocali personalizzate, nell’obiettivo di ottimizzarne la progettazione utilizzando i dati gener…
Chris R. Stark Joins EyeCare Services Partners as Vice President, Managed Care
DALLAS–(BUSINESS WIRE)–EyeCare Services Partners (ESP), the national leader in integrated eye care services, announced today that Chris R. Stark recently joined the Company as Vice President, Managed Care. Mr. Stark is responsible for the firm’s cont…
SparingVision Wins First Prize at EIT European Health Catapult Competition
PARIS–(BUSINESS WIRE)–SparingVision wins First Prize at EIT European Health Catapult competition.